Read clinical review Clinical review of the tirzepatide (Mounjaro) and gabapentin drug interaction, covering pharmacokinetic mechanisms, safety data, dose-adjustment guidance, and monitoring recommendations
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Watkins A.R., Fialka N., El-Andari R., Kang J.J., Bozso S.J., Nagendran J
Repeated measurements of endocrine markers were analyzed with linear mixed-effects (LME) models, having drug condition (placebo, oral cannabis, smoked cannabis, and vaporized cannabis), session number (1, 2, 3, and 4), blood sampling time-point (T1, T2, T3, and T4), and drug time-point interaction as fixed effects, individual subjects as a random effect (random intercept and slope), and each hormone as the outcome
doi: 10.1016/S2213-8587(18)30104-9
Exenatide, a synthetic version of exendin-4 produced industrially, was the first GLP-1RA approved for the market [exenatide twice daily (EX-BID)], followed by a long-acting formulation that improved the delivery system [exenatide once a week (EX-QW)]